C07C233/18

Cytotoxic actin-targeting compounds

A class of compounds useful in pharmaceutical compositions and methods for treating or preventing cancer is described. Analogs of Mycalolide B have been prepared and tested in breast and ovarian cancer cell lines. The compounds show utility for inhibition of survival and proliferation of tumor cells. The compounds have been shown to disrupt actin.

Aromatic amides having a fungicidal activity, their agronomic compositions and relative preparation method

Aromatic amides are described, having general formula (I): ##STR00001##
suitably substituted and having a high fungicidal activity, together with their use for controlling phytopathogenic fungi of important agricultural crops.

Aromatic amides having a fungicidal activity, their agronomic compositions and relative preparation method

Aromatic amides are described, having general formula (I): ##STR00001##
suitably substituted and having a high fungicidal activity, together with their use for controlling phytopathogenic fungi of important agricultural crops.

Pseudoceramide compound and skin external composition comprising the same
11345655 · 2022-05-31 · ·

Provided are a novel pseudoceramide compound and a skin external composition comprising the same. The skin external composition comprising a pseudoceramide compound or a pharmaceutically acceptable salt or solvate thereof according to the present invention as an active ingredient has an excellent effect of improving a skin barrier function, thereby exhibiting an effect of improving inflammatory skin diseases, and also is excellent in the function of improving the skin barrier and the effect of enhancing skin moisture.

Pseudoceramide compound and skin external composition comprising the same
11345655 · 2022-05-31 · ·

Provided are a novel pseudoceramide compound and a skin external composition comprising the same. The skin external composition comprising a pseudoceramide compound or a pharmaceutically acceptable salt or solvate thereof according to the present invention as an active ingredient has an excellent effect of improving a skin barrier function, thereby exhibiting an effect of improving inflammatory skin diseases, and also is excellent in the function of improving the skin barrier and the effect of enhancing skin moisture.

Sphingosine kinase Type 1 inhibitors and uses thereof

Provided are inhibitors of sphingosine kinase Type I that are useful in the treatment of neuropathic pain.

Sphingosine kinase Type 1 inhibitors and uses thereof

Provided are inhibitors of sphingosine kinase Type I that are useful in the treatment of neuropathic pain.

NOVEL SPHINGOLIPID CONTAINING BRANCHED-CHAIN FATTY ACID AND USE THEREOF

A topical skin composition containing a sphingolipid having a branched chain fatty acid as an active ingredient and its uses are disclosed. The topical composition is useful in preventing adsorption of fine dust, improving a skin barrier function, and exhibiting an excellent skin moisture effect. A preparation method for the topical composition is also disclosed.

PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE

The present invention relates to a process for the preparation of the active pharmaceutical ingredient Fingolimod Hydrochloride (I) and its highly pure intermediate [2-acetamido-2-(acetyloxy methyl)-4-phenylbutyl] acetate(II)

##STR00001##

PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE

The present invention relates to a process for the preparation of the active pharmaceutical ingredient Fingolimod Hydrochloride (I) and its highly pure intermediate [2-acetamido-2-(acetyloxy methyl)-4-phenylbutyl] acetate(II)

##STR00001##